These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15373048)

  • 1. [HAART and pregnancy. Nelfinavir superiority in hepatotoxicity].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():45. PubMed ID: 15373048
    [No Abstract]   [Full Text] [Related]  

  • 2. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of birth defects associated with nelfinavir exposure during pregnancy.
    Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
    Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side effects and complications. Risk of deformities very low in infants exposed to HAART.
    TreatmentUpdate; 2009 Feb; 21(2):8-9. PubMed ID: 19391265
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined antiretroviral therapy during pregnancy and risk of congenital malformations.
    Frieden IJ; Haggstrom AN; McCulloch C; Drolet B; Esterly NB; Garzon MC; Lucky AW; Baselga E; Friedlander SF
    JAMA; 2004 Apr; 291(16):1961-2; author reply 1962. PubMed ID: 15113813
    [No Abstract]   [Full Text] [Related]  

  • 6. Considerations on the potential teratogenic effects of antiretroviral therapy.
    Meli M; Vicidomini S; Bartoloni A
    Intern Emerg Med; 2006; 1(3):249-50. PubMed ID: 17120478
    [No Abstract]   [Full Text] [Related]  

  • 7. Fulminant hepatic failure associated with antiretroviral therapy in a pregnant woman.
    Stohl HE; Silva AM; Argani CH; Anderson JR
    Int J Gynaecol Obstet; 2009 Sep; 106(3):260-1. PubMed ID: 19477440
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic safety and HAART.
    McGovern B
    J Int Assoc Physicians AIDS Care (Chic); 2004 Nov; 3 Suppl 2():S24-40. PubMed ID: 15673131
    [No Abstract]   [Full Text] [Related]  

  • 9. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatotoxicity with antiretroviral therapy. The liver is affected as well].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():14-5. PubMed ID: 12043064
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Thorne C; Fiore S; Rudin C
    N Engl J Med; 2003 Jan; 348(5):471-2; author reply 471-2. PubMed ID: 12556551
    [No Abstract]   [Full Text] [Related]  

  • 12. Side effects and complications. HAART and the safety of the fetus.
    TreatmentUpdate; 2009 Feb; 21(2):6-7. PubMed ID: 19391263
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatotoxicity with antiretroviral treatment of pregnant women.
    Hill JB; Sheffield JS; Zeeman GG; Wendel GD
    Obstet Gynecol; 2001 Nov; 98(5 Pt 2):909-11. PubMed ID: 11704198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.
    Scarsi KK; Postelnick MJ
    J Gend Specif Med; 2003; 6(1):7-16. PubMed ID: 12661172
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.
    Núñez M
    Hepatology; 2010 Sep; 52(3):1143-55. PubMed ID: 20812358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [German-Austrian guidelines for HIV therapy during pregnancy (May, 2001, update].
    Buchholz B; ;
    Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S19-31. PubMed ID: 12736864
    [No Abstract]   [Full Text] [Related]  

  • 18. Twins with cardiomyopathy and complete heart block born to an HIV-infected mother treated with HAART.
    Lopriore E; Rozendaal L; Gelinck LB; Bökenkamp R; Boelen CC; Walther FJ
    AIDS; 2007 Nov; 21(18):2564-5. PubMed ID: 18025905
    [No Abstract]   [Full Text] [Related]  

  • 19. Side effects and complications. French study clears HAART of cancer link in kids.
    TreatmentUpdate; 2009 Feb; 21(2):7-8. PubMed ID: 19391264
    [No Abstract]   [Full Text] [Related]  

  • 20. Inclusion of women in clinical trials of antiretroviral agents for HIV/AIDS during pregnancy.
    Mangino JE; Fass RJ
    Lancet; 1997 Jul; 350(9071):150. PubMed ID: 9228998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.